Aesthetic gynecology is rapidly evolving from a niche subspecialty into a structured, evidence-supported clinical field. Today’s patients expect not only symptom relief, but comprehensive, minimally invasive solutions that restore tissue integrity, functional performance and long-term quality of life. As a result, modern gynecological practice increasingly integrates structural reinforcement, regenerative stimulation and energy-based technologies within cohesive treatment strategies.
Thread Technologies: Structural Reinforcement with Biostimulation
Thread lifting in urogynecology has developed into a minimally invasive method of structural reinforcement aimed at improving both biomechanical stability and tissue quality. Contemporary approaches focus not solely on aesthetic correction, but on restoring support mechanisms within vaginal and perineal tissues while simultaneously stimulating regenerative processes.
The Aptos Intimate Excellence Method HA represents a third-generation absorbable thread specifically designed for intimate indications. Based on a copolymer of polylactic acid and polycaprolactone (P(LA/CL)) and enriched with hyaluronic acid, this system combines mechanical support with biological stimulation. According to the methodological guide on intimate thread lifting [1], polylactic acid promotes collagen types I and III synthesis, while polycaprolactone supports controlled degradation and durability of the lifting effect. The addition of hyaluronic acid contributes to improved tissue hydration and may reduce the intensity of post-procedural inflammatory response.
Histological observations describe the formation of a connective tissue capsule around the multidirectional barbs of the thread, leading to collagen and elastin remodeling. Although the material gradually biodegrades over approximately 1.5–2 years, the newly formed connective framework remains, supporting sustained tissue integrity [1].
In clinical gynecological practice, this approach is applied for vaginal wall reinforcement, correction of perineal defects, labial reshaping and support in cases of pelvic floor relaxation. The concept often referred to as “bio-armoring” reflects a broader shift within aesthetic gynecology toward functional regeneration rather than purely cosmetic correction.

Exosomes & Regenerative Protocols: Enhancing Tissue Recovery and Cellular Communication
While structural support addresses biomechanical integrity, regenerative protocols operate at the cellular level, enhancing tissue recovery and biological communication. In this context, exosomes have emerged as one of the most promising biologically inspired innovations in aesthetic medicine.
A 2024 review published in Cosmetics highlights the critical role of extracellular vesicles in intercellular communication and tissue regeneration [2]. Exosomes transport proteins, lipids, mRNA and growth factors that modulate inflammatory pathways, stimulate fibroblast activity and support extracellular matrix remodeling. Their biological activity has been associated with anti-inflammatory and antioxidant effects, as well as stimulation of collagen and elastin synthesis [2].
In aesthetic gynecology, exosomes are increasingly integrated into post-procedural protocols, particularly following laser, radiofrequency or microneedling treatments where controlled tissue stimulation requires optimized regenerative support. They are also used in the management of atrophic mucosa and as part of combination rejuvenation strategies aimed at improving hydration, elasticity and recovery dynamics.
ASCEplus Intimate Care IRLV by ExoCoBio represents a targeted application of exosome-based regenerative concepts for intimate indications, aligning clinical practice with emerging evidence in regenerative medicine [2]. The growing interest in such protocols reflects a transition from symptomatic correction toward biologically driven, cellular-level strategies that complement structural reinforcement techniques.

Energy-Based Devices: Precision Stimulation and Functional Restoration
As aesthetic gynecology advances toward integrated, evidence-based care, energy-based devices have assumed a central role by delivering precise and reproducible biological stimulation. Their application has become fundamental in the management of genitourinary syndrome, vaginal laxity and pelvic floor dysfunction.
Radiofrequency (RF) technologies are among the most extensively studied modalities in this field. A 12-month prospective cohort study evaluating radiofrequency ablation of the vaginal canal demonstrated statistically significant improvement in Vaginal Health Index Scores (VHIS) and genitourinary symptoms, without serious adverse events [5]. Controlled thermal energy promotes neocollagenesis, elastogenesis and increased vascularization, contributing to improved tissue hydration and structural resilience. These mechanisms form the scientific basis of RF-based platforms such as EmpowerRF, which are increasingly incorporated into structured intimate health protocols.

Beyond tissue remodeling, functional rehabilitation of the pelvic floor has become an essential dimension of modern practice. High-Intensity Tesla Stimulation (HITS®) technology induces supramaximal muscle contractions through pulsed magnetic fields and motor neuron activation. Clinical review data describe improvements in neuromuscular control and urinary incontinence symptoms [3], while international end-user surveys report high efficacy ratings and a favorable safety profile in routine clinical use [4]. Systems such as Fotona StarFormer integrate this technology into non-invasive pelvic floor strengthening programs, expanding therapeutic possibilities beyond tissue-level interventions.

Laser technologies further complement these approaches by promoting collagen remodeling and mucosal regeneration through controlled photothermal effects. Platforms such as Fotona TimeWalker IntimaLaser are frequently incorporated into combination strategies, particularly when supported by regenerative adjuncts that optimize post-procedural recovery and tissue quality.

Toward Integrated, Multimodal Protocols
What emerges clearly from both clinical literature and practical experience is a move toward multimodal treatment strategies. Structural reinforcement with threads, cellular-level support through exosomes, thermal remodeling via RF or laser, and functional rehabilitation through electromagnetic stimulation are no longer applied in isolation. Instead, they are combined within cohesive protocols designed to address vaginal laxity, atrophic changes, stress urinary incontinence, postpartum remodeling and broader manifestations of genitourinary syndrome.
Modern aesthetic gynecology is therefore evolving into a comprehensive regenerative discipline in which technological precision and biological understanding converge. Rather than focusing on isolated interventions, contemporary practice integrates structural, regenerative and functional approaches to deliver predictable, evidence-supported outcomes and long-term improvement in women’s intimate health.
REFERENCES
-
Sulamanidze M, Alikberova S, Leshunov E, Markova N, Titovets Y, Tomadze T. Intimate Thread Lifting Methods: Methods Guide. Aptos; 2020;
-
Rodriguez C, Porcello A, Chemali M, Raffoul W, Marques C, Scaletta C, et al. Medicalized aesthetic uses of exosomes and cell culture-conditioned media: opening an advanced care era for biologically inspired cutaneous prejuvenation and rejuvenation. Cosmetics. 2024;
-
Talaber I, Koron N, Bucik M, Baños J, Valdivia Sing R, Štrumbelj T, Hreljac I. Introduction to High Intensity Tesla Stimulation (HITS®) with StarFormer® and review of electro-magnetic field device clinical applications. J Laser Health Acad. 2021;
-
Vesel J, Pajk F, Jagodic Š, Jelenc J, Hreljac I. End user survey on the use of High Intensity Tesla Stimulation (HITS®) magnetic devices. J Laser Health Acad. 2021;
-
Rothenberger RW, Kopinga E, Dell J, Moore RD, Miklos JR, Karram M. Use of radiofrequency ablation of the vaginal canal for genitourinary syndrome of menopause: a prospective cohort study with 12-month follow-up. Menopause. 2025;32(9):000–000.